Living in a different world

Arthritis and Rheumatism

Volumn 52, Issue 2, 2005, Pages 395-401

  Wofsy, David ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b American College of Rheumatology   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; ROFECOXIB;

BIOSAFETY; COMMERCIAL PHENOMENA; CONFERENCE PAPER; CORRELATION ANALYSIS; DECISION MAKING; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; FUTUROLOGY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLISHING; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

DRUG INDUSTRY; FELLOWSHIPS AND SCHOLARSHIPS; HUMANS; RESEARCH SUPPORT; RHEUMATIC DISEASES; RHEUMATOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 13444274312     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20865     Document Type: Conference Paper

References (2)

1. Davidoff F. The heartbreak of drug pricing. Ann Intern Med 2001;134:1068-71.
2. US promotional spending on prescription drugs, 2002. CMAJ 2003;169:699.